Group Mailing 2000-11-01

Priority Lists

Disease Committee	Last Changed
Breast Cancer	3/6/26
Cancer Care Delivery	8/4/25
comboMATCH	10/16/25
Early Therapeutics & Rare Cancers	11/7/25
Gastrointestinal Cancer	12/30/25
Genitourinary Cancer	1/19/26
Head and Neck Cancer	10/16/25
iMATCH	12/3/25
Immunomolecular Therapeutics	12/3/25
Leukemia	12/30/25
Lung Cancer	9/8/25
LungMAP	4/24/25
Lymphoma	10/23/25
Melanoma	11/7/25
Myeloma	10/23/25
myeloMATCH	12/30/25
Other	2/1/14
Palliative Care	10/24/25
Prevention, Screening, and Surveillance	1/1/25
Sarcoma	9/15/07
SWOG CTP	10/16/25
Symptom Management and Survivorship	10/24/25

Scroll Table

Activations

S0007Phase II

Evaluation of 3 Hour Infusion of Paclitaxel Plus Cisplatin and 5-Fluorouracil in Patients with Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Study Coordinator(s)	Maha H.A. Hussain, M.D., Wolfram E. Samlowski, M.D.
Participants	Members, NCORP, Medical Oncologists

Closures

Amendments, Revisions, Memoranda

Other New Items

IP - Pts Must Be Informed
AC - Consent Must Be Amended
CBR - No Registration Allowed until IRB Review
RC - Formal Re-consent Required
FBR - Full Board Review Required
ER - Expedited Review Acceptable
NR - No IRB Review Required

Trial & Business Updates: 11/1/2000

Priority Lists

Protocol Posting of 11/1/2000

Activations

Closures

Amendments, Revisions, Memoranda

Other New Items